Free Newsletter
FDA panel: No cold meds for under-6 kids
The concerns about cough-and-cold meds for kids culminated Friday in an FDA advisory group vote against the products. The expert group concluded that there's not enough evidence that the drugs work--and plenty of evidence that they can be harmful--so they shouldn't be used in children under the age of 6.
The 13-to-9 decision was by no means unanimous, though. Some panelists believe parents depend on the drugs for help when a child is sick. Americans spend more than $300 million a year on these products. The agency probably will work with the industry to come up with a voluntary action plan, because formal proceedings could take years, FDA officials told the Washington Post.
- read the report from the Washington Post
Related Articles:
FDA experts mull ban on child cold meds. Report
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: